Overview

A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Investigate genetic variability of CES1 gene on pharmacokinetics of oseltamivir in healthy Korean volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Oseltamivir